Diwakar Bahuguna

• Set up a CoE for oncology and cardiology in Saudi Arabia; infrastructure and workforce recommendations led to a 40% increase in patient volume in year one • Led 3 integration and carve-out projects for life sciences clients across the US and EU, achieving 15–20% cost reduction through detailed performance benchmarking & synergy identification • Supported commercial and operational due diligence and strategic planning for 4+ life sciences clients in the US/EU, contributing to ~$100K in total project value

• Delivered market entry and GTM strategy for MedTech and pharma clients, including a successful orthopedic device version upgrade launch in Australia for a leading orthopedic manufacturer, achieving a 15% price premium • Developed stakeholder-specific value messaging for a bladder cancer portfolio launch in SEA for a top-tier pharmaceutical company; shaped strategy on where to play and how to play • Led indication prioritization projects for rare indications (total value: $400K) for Japanese manufacturers

• Conducted in-depth market research and developed procedure and sales forecast models • Supported launch readiness and pricing strategy for orthopedic and aesthetic products (e.g., bone grafts, botulinum toxins, etc.), advising on reimbursement potential and market fit • Guided global market expansion strategy for leading orthopedic firms through 50+ primary interviews • Authored 10+ syndicated reports and 4+ blogs on orthopedics/aesthetics incorporating insights from primary and secondary research

• Independently worked on a competitive intelligence project, to track down DRG's competitors for M360 and its offerings in the medical device space. Project required active involvement with the MedTech managers and sales team for inputs, followed by presentation and discussion with the leadership team.